100 related articles for article (PubMed ID: 14644505)
1. Chimeric transcriptional control units for improved liver-specific transgene expression.
Gehrke S; Jérôme V; Müller R
Gene; 2003 Dec; 322():137-43. PubMed ID: 14644505
[TBL] [Abstract][Full Text] [Related]
2. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo comparative study of chimeric liver-specific promoters.
Kramer MG; Barajas M; Razquin N; Berraondo P; Rodrigo M; Wu C; Qian C; Fortes P; Prieto J
Mol Ther; 2003 Mar; 7(3):375-85. PubMed ID: 12668133
[TBL] [Abstract][Full Text] [Related]
4. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
[TBL] [Abstract][Full Text] [Related]
5. [Improvement of transcriptional activity of hTERT promoter by SV40 enhancer].
Zhang WM; Xue LY; Xu Y; Xing J; Geng X; Wang D; Li YY
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):691-3. PubMed ID: 17374218
[No Abstract] [Full Text] [Related]
6. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
Lam PY; Sia KC; Khong JH; De Geest B; Lim KS; Ho IA; Wang GY; Miao LV; Huynh H; Hui KM
Mol Ther; 2007 Jun; 15(6):1129-36. PubMed ID: 17426711
[TBL] [Abstract][Full Text] [Related]
7. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
8. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
9. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol and bile acids regulate cholesterol 7 alpha-hydroxylase expression at the transcriptional level in culture and in transgenic mice.
Ramirez MI; Karaoglu D; Haro D; Barillas C; Bashirzadeh R; Gil G
Mol Cell Biol; 1994 Apr; 14(4):2809-21. PubMed ID: 8139578
[TBL] [Abstract][Full Text] [Related]
11. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
Riu E; Grimm D; Huang Z; Kay MA
Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
Guo ZS; Wang LH; Eisensmith RC; Woo SL
Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
[TBL] [Abstract][Full Text] [Related]
13. Insulators prevent transcriptional interference between two promoters in a double gene construct for transgenesis.
Hasegawa K; Nakatsuji N
FEBS Lett; 2002 Jun; 520(1-3):47-52. PubMed ID: 12044868
[TBL] [Abstract][Full Text] [Related]
14. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.
Argyros O; Wong SP; Niceta M; Waddington SN; Howe SJ; Coutelle C; Miller AD; Harbottle RP
Gene Ther; 2008 Dec; 15(24):1593-605. PubMed ID: 18633447
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
16. Analysis of gene structures and promoter activities of the chipmunk alpha(1)-antitrypsin-like genes.
Nakazawa A; Inaba Y; Kamijima A; Kondo N; Ito M; Shiba T; Takamatsu N
Gene; 2004 Mar; 329():71-9. PubMed ID: 15033530
[TBL] [Abstract][Full Text] [Related]
17. Effect of tissue-specific promoters and microRNA recognition elements on stability of transgene expression after hydrodynamic naked plasmid DNA delivery.
Wolff LJ; Wolff JA; Sebestyén MG
Hum Gene Ther; 2009 Apr; 20(4):374-88. PubMed ID: 19199823
[TBL] [Abstract][Full Text] [Related]
18. Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.
Schüttrumpf J; Milanov P; Abriss D; Roth S; Tonn T; Seifried E
Hum Gene Ther; 2011 Jan; 22(1):101-6. PubMed ID: 20677911
[TBL] [Abstract][Full Text] [Related]
19. HNF3beta and GATA-4 transactivate the liver-enriched homeobox gene, Hex.
Denson LA; McClure MH; Bogue CW; Karpen SJ; Jacobs HC
Gene; 2000 Apr; 246(1-2):311-20. PubMed ID: 10767553
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
Al-Dosari M; Zhang G; Knapp JE; Liu D
Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
